All News

Patient Encourages Others to ‘Continue Living’ After a Myeloma Diagnosis By Advocating

March 2nd 2022

As part of its Speaking Out video series, CURE spoke with Throwing Bones founder, Kenny Caps, about raising awareness for multiple myeloma, and why sharing one’s story is helpful for others.

Addition of Ofatumumab to Aggressive Chemotherapy Regimen Yields High Response Rates in Newly Diagnosed Mantle Cell Lymphoma

March 2nd 2022

Treatment with ofatumumab plus an aggressive regimen of chemotherapies resulted in a response rate of more than 80% in patients with newly diagnosed mantle cell lymphoma.

Drug Duo Sparks Encouraging Outcomes in Treatment of Clear Cell Kidney Cancer

March 1st 2022

In a recent clinical trial, treatment with Bavencio plus Inlyta produced promising outcomes in the presurgical treatment of patients with non-metastatic, clear cell renal cell carcinoma.

‘Tremendous Hope’ Surrounds Emerging Therapies for Cancer That has Spread to the Brain

March 1st 2022

Better therapies are on the horizon for cancer that has spread to the brain, including a clinical trial that matches patients with treatments based on unique genetic changes in brain metastases.

Social Media Led Me to Lasting Bonds and Cancer Camaraderie

March 1st 2022

In spending just a few minutes a day on Twitter, I’ve created a support group with other cancer survivors who know how it feels to face the disease.

FDA Grants Accelerated Approval to Vonjo for Myelofibrosis With Severe Thrombocytopenia

March 1st 2022

The Food and Drug Administration’s greenlight of Vonjo marks the first approved therapy to address the needs of patients with cytopenic myelofibrosis, a type of myeloproliferative neoplasm.

FDA Approves Carvykti, a CAR-T Cell Therapy, for Pretreated Relapsed/Refractory Myeloma

March 1st 2022

Ninety-eight percent of patients with pretreated relapsed/refractory myeloma responded to treatment with Carvykti, a newly approved CAR-T cell therapy for this patient population.

New App Aims to Improve the Lives of ‘Core of Our Health Care System’ — Cancer Caregivers

February 28th 2022

When caregivers — considered by many to be an essential part of a patient’s care team — have the tools they need to care for themselves and their loved ones, cancer outcomes can be better, too.

My Only Gift From Cancer: a New View on Life

February 28th 2022

When I was diagnosed with cancer, I thought of only two things: my loved ones and how much time I had left with them.

Fellow Cancer Survivor Helps Me Snap Out of Post-Scanxiety Blues

February 28th 2022

The post-scanxiety crash felt like an avalanche for me, and even though my scans were clear, it took talking to another cancer survivor to snap me out of it.

Opdivo Gets FDA Priority Review for Presurgical NSCLC Treatment

February 28th 2022

The Food and Drug Administration plans to speed up its review of Opdivo in the pre-surgical setting for patients with non-small cell lung cancer.

New Treatments Lend a Positive Outlook to Patients With GVHD

February 28th 2022

There are now more drugs than ever to treat and prevent graft-versus-host disease in patients with blood cancer who receive a stem cell transplant.

An ‘Equal Playing Field’ Makes up the Available Treatment Options for CLL

February 27th 2022

Regardless of a patient’s age, comorbidity status or disease risk, an expert from Memorial Sloan Kettering Cancer Center notes how targeted therapies have become the standard of care in treating chronic lymphocytic leukemia.

Ending Metastatic Breast Cancer for Everyone

February 26th 2022

Dr. Nancy U. Lin actors as a mentor for her patients, helping to guide them through the cancer experience, says her colleague Dr. Ines Vaz-Luis.

Here Are Some Tips to Help You Freeze Out Those Winter Blues and Seasonal Affective Disorder

February 25th 2022

As a cancer survivor, I know all too well the struggles with depression and sadness. Fold in those grey winter days and It makes for a disastrous recipe.

‘America’s Got Talent’ Contestant Jane ‘Nightbirdie’ Marczewski Dies 4 Years After Cancer Diagnosis, ‘Good Morning America’s’ Robin Roberts Announces Partner’s Cancer Diagnosis and More

February 25th 2022

From the death of “America’s Got Talent” contestant Jane “Nightbirdie” Marczewski to “Good Morning America” anchor Robin Roberts announcing her partners breast cancer diagnosis, here’s what’s happening in the cancer space this week.

Experimental Lymphoma Drug Shows ‘Robust Clinical Activity,’ Researchers Say

February 25th 2022

Treatment with TRPH-222 led to lasting responses in certain patients with relapsed/refractory B-cell non-Hodgkin lymphomas, warranting a larger investigation into the drug, according to the researchers.

Although Cancer Can Damage Body Image, One Survivor Sought to 'Love Herself From the Inside'

February 24th 2022

Sara Montiel says she experienced severe body image issues after her breast cancer diagnosis and subsequent double mastectomy, but she now recalls how she learned to realize how cancer was a blessing.

My Daughter Chose When — and How — She Was Going to Lose Her Hair to Cancer

February 24th 2022

Chemotherapy treatments for breast cancer would likely cause my daughter to lose her hair, but instead of waiting for her locks to fall out on their own, she took matters into her own hands.

Combatting Chemo with Kindness While Facing TNBC at the Age of 28

February 24th 2022

The 16-week challenge was simple: do something kind each week during my chemo treatment and tell me about it on social media. The goal was ambitious: 1,600 acts.

Families Need to Be More Open About Cancer Risks, Because it Could Save the Life of Someone You Love

February 24th 2022

Last year, my wife died of triple-negative breast cancer that was caused by a genetic mutation. If her family risk was discussed more openly, she — and many others with an inherited predisposition to cancer — may still be here today.

Enhertu Outperforms Chemotherapy in HER2-Low Unresectable/Metastatic Breast Cancer

February 23rd 2022

Treatment with Enhertu was associated with improved survival across several subgroups of patients with metastatic breast cancer, compared with standard-of-care chemotherapy.

Did Surviving Cancer Flip the Script on How I Was Treated on Social Media?

February 23rd 2022

Nina Luker has shared her journey with diffuse large B-cell lymphoma on social media with more than 100,000 followers, but says she noticed a difference in the kinds of comments she received after treatment was over and she was deemed “not as vulnerable” anymore.

I’m a Male Breast Cancer Survivor and My ‘Breast Cancer Sisters’ Helped Me Get Through It

February 23rd 2022

Getting men to talk about their breast health is like fishing in an under-stocked pond, so I turn to the advice of my breast cancer sisters.

My Cancer Diagnosis Led Me to Discover a Family I Didn’t Know I Had

February 23rd 2022

After being diagnosed with stage 2 colorectal cancer, I discovered that I had two sisters — and a family predisposition to cancer.

Advancing Outcomes and Quality of Life for Patients With Metastatic Cancer

February 23rd 2022

Dr. Nancy U. Lin dedicated her life to improving outcomes for patients with metastatic breast cancer. In this essay, a colleague honors her hard work.

Photoimmunotherapy Trial Begins in Certain Patients With Head and Neck, and Skin Cancer

February 22nd 2022

The goal of the phase 2 trial is to study the safety and efficacy of ASP-1929, a photoimmunotherapy with fluorescence imaging, in patients with head and neck or skin cancer.

Cabometyx Before Surgery May Shrink Tumors With No Disease Progression in Advanced Kidney Cancer

February 22nd 2022

Treatment with Cabometyx before surgery in patients with advanced renal cell carcinoma, a type of kidney cancer, may provide benefits, although further research is required before a decision is made about its role in presurgical treatment.

‘Boys Don’t Cry’: How Men Can ‘Wrangle Emotions’ While Facing Cancer

February 22nd 2022

Facing cancer can be perplexing for some men as many of us were raised within the “boys don’t cry” ilk, but I want to remind everyone that it’s OK to feel emotions.

Updated Results on Lenvima-Keytruda Combo ‘Still Encouraging’ for Patients With Advanced Kidney Cancer, Expert Says

February 22nd 2022

Although the data failed to identify a predictive biomarker in patients with advanced kidney cancer, an expert from Memorial Sloan Kettering Cancer Center in New York notes that the results indicate that no one should be excluded from receiving Lenvima plus Keytruda.